Dual antiplatelet therapy in patients with minor stroke receiving intravenous thrombolysis
Z Xu, N Chen, H Sun, T Jiang, Q Deng, J Zhou… - Frontiers in …, 2022 - frontiersin.org
Introduction Concern over the potential severe bleeding risk of dual antiplatelet therapy for
patients with minor stroke after intravenous thrombolysis (IVT) leads to different antiplatelet …
patients with minor stroke after intravenous thrombolysis (IVT) leads to different antiplatelet …
Predictive value of whole-brain CT perfusion combined with ABCD3 score for short-term secondary cerebral infarction after TIA
S Liu, T Chen, W Wu - Frontiers in Neurology, 2023 - frontiersin.org
Objective To investigate the predictive value of Whole Brain CT Perfusion (WB-CTP)
combined with the ABCD3 score in patients with transient ischemic attack (TIA). Methods A …
combined with the ABCD3 score in patients with transient ischemic attack (TIA). Methods A …
Antiplatelet therapy for transient ischemic attack and minor stroke
Transient ischemic attack (TIA) and minor stroke account for 30% to 50% of all cerebral
ischemic events around the world. 1, 2 In the acute setting, mono-antiplatelet therapy …
ischemic events around the world. 1, 2 In the acute setting, mono-antiplatelet therapy …
Management of ischaemic stroke survivors in primary care setting: the road to holistic care
H Ozdemir, D Sagris, AH Abdul-Rahim, GYH Lip… - Internal and Emergency …, 2024 - Springer
The management of ischaemic stroke survivors is multidisciplinary, necessitating the
collaboration of numerous medical professionals and rehabilitation specialists. However …
collaboration of numerous medical professionals and rehabilitation specialists. However …
[HTML][HTML] Dual antiplatelet therapy improves functional recovery and inhibits inflammation after cerebral ischemia/reperfusion injury
W Dong, X Liu, W Liu, C Wang, S Zhao… - Annals of …, 2022 - ncbi.nlm.nih.gov
Background Dual antiplatelet therapy with aspirin and clopidogrel (ASA+ CPG) during the
first 21 days has been shown to reduce the risk of major ischemic events in patients with …
first 21 days has been shown to reduce the risk of major ischemic events in patients with …
Intrinsic stenosing and occlusive pathologies of the vertebral artery: A narrative review
PN Correia, IA Meyer, C Odier - Neurochirurgie, 2024 - Elsevier
Intrinsic pathologies of the vertebral arteries, such as atherosclerosis, dissection,
fibromuscular dysplasia, radionecrosis and vasculitis, are important causes of …
fibromuscular dysplasia, radionecrosis and vasculitis, are important causes of …
Dual anti-platelet therapy for secondary prevention in intracranial atherosclerotic disease: a network meta-analysis
G Reale, A Zauli, G La Torre… - Therapeutic …, 2022 - journals.sagepub.com
Background: Intracranial arterial stenosis (ICAS) is a non-marginal cause of stroke/transient
ischemic attacks (TIAs) and is associated with high stroke recurrence rate. Some studies …
ischemic attacks (TIAs) and is associated with high stroke recurrence rate. Some studies …
Dual antiplatelet therapy for ischemic stroke with intracranial arterial stenosis: a systematic review and meta-analysis
H Shao, S He, P Ni, D Zheng, N Yu, Q Chen… - Frontiers in …, 2024 - frontiersin.org
Background The safety and efficacy of dual antiplatelet therapy (DAPT) in ischemic stroke
patients with intracranial artery stenosis (ICAS) remain contentious. Aims This study …
patients with intracranial artery stenosis (ICAS) remain contentious. Aims This study …
Optimal duration of dual antiplatelet therapy for minor stroke within 72 hours of symptom onset: a prospective cohort study
T Liu, Y Wang, K Zhang, H Fan, Y Li, J Ren… - Stroke and Vascular …, 2024 - svn.bmj.com
Objectives Despite the potential spillover effect, the optimal duration of dual antiplatelet
therapy for minor stroke within 72 hours of symptom onset is still uncertain. Methods Safety …
therapy for minor stroke within 72 hours of symptom onset is still uncertain. Methods Safety …